These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31200993)

  • 1. Vaginal brachytherapy alone for patients with Stage II endometrial cancer with inner half cervical stromal invasion.
    Barnes EA; Parra-Herran C; Martell K; Barbera L; Taggar A; Leung E
    Brachytherapy; 2019; 18(5):606-611. PubMed ID: 31200993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
    Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
    Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
    Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
    Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
    Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
    Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
    Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
    Eltabbakh GH; Piver MS; Hempling RE; Shin KH
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma.
    Harkenrider MM; Martin B; Nieto K; Small C; Aref I; Bergman D; Chundury A; Elshaikh MA; Gaffney D; Jhingran A; Lee L; Paydar I; Ra K; Schwarz J; Thorpe C; Viswanathan AN; Small W
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1069-1077. PubMed ID: 29885996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
    AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
    Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study.
    Brodeur MN; Samouëlian V; Dabi Y; Cormier B; Beauchemin MC; Barkati M
    Int J Gynecol Cancer; 2021 Jan; 31(1):78-84. PubMed ID: 33127863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
    Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen TT; Stone RL; Wethington SL; Fader AN; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan A; Ricci S
    Int J Gynecol Cancer; 2020 Nov; 30(11):1738-1747. PubMed ID: 32771986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
    Horowitz NS; Peters WA; Smith MR; Drescher CW; Atwood M; Mate TP
    Obstet Gynecol; 2002 Feb; 99(2):235-40. PubMed ID: 11814503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
    Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.